Imaging fibroblast activation protein in liver cancer: a single-center post hoc retrospective analysis to compare [68Ga]Ga-FAPI-04 PET/CT versus MRI and [18F]-FDG PET/CT.
Wei GuoYizhen PangLanlin YaoLiang ZhaoChunlei FanJingpeng KePing GuoBing HaoHao FuChengrong XieQin LinHua WuLong SunHaojun ChenPublished in: European journal of nuclear medicine and molecular imaging (2020)
Our findings indicate that the sensitivity of [68Ga]Ga-FAPI-04 PET/CT to correctly identify primary liver tumors and metastatic lesions is equivalent to that of CE-CT and liver MRI. Moreover, [68Ga]Ga-FAPI-04 PET/CT is better at identifying liver lesions than [18F]-FDG PET/CT, and its use may improve tumor staging, recurrence detection, and implementation of necessary treatment modifications.